Capricor Therapeutics, Inc.

Healthcare · Biotechnology · United States

Last price 6.63 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 385.46M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Capricor Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States. Its lead product candidate is the Deramiocel, an allogeneic cardiosphere-derived cells, which is in phase 3 clinical trial for the treatment of DMD. The company also develops Exosome protein-based vaccine, which is in preclinical trial to treat SARS-CoV-2; StealthX Exosome Platform, and...